Atlas Trials

A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

Clinical trial NCT07572812 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07572812
Sponsor
Shanghai UniXell Biotechnology Co., Ltd
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Epilepsy
Start date
2026-08-20
Primary completion
2029-07-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.